Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The myelodysplastic syndromes.

R L Verwilghen1, M A Boogaerts

  • 1Department of Haematology, University Hospital, Leuven, Belgium.

Blood Reviews
|March 1, 1987
PubMed
Summary

Myelodysplastic syndromes are premalignant clonal disorders characterized by ineffective blood cell production. About one-third of patients progress to acute leukemia, while others face bone marrow failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Epidemiology of Chronic Digestive Disease.

Acta clinica Belgica·2016
Same author

Antifungal prophylaxis in neutropenia.

Current opinion in infectious diseases·2006
Same author

Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.

Leukemia & lymphoma·2002
Same author

Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells.

Clinical and experimental immunology·2001
Same author

Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.

Nature genetics·2001

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are clonal premalignant disorders affecting hematopoietic stem cells.
  • Characterized by ineffective blood cell maturation and a risk of transformation to acute myeloid leukemia (AML).
  • Primarily affects the elderly, with a moderate male predominance and unknown incidence.

Purpose of the Study:

  • To provide a comprehensive overview of myelodysplastic syndromes.
  • To discuss the pathogenesis, clinical features, and genetic abnormalities associated with MDS.
  • To review current treatment strategies and emerging developments.

Main Methods:

  • Review of existing literature on myelodysplastic syndromes.
  • Analysis of epidemiological data, clinical characteristics, and cytogenetic findings.
  • Discussion of etiological factors and treatment outcomes.

Main Results:

  • MDS involves dysplastic hematopoiesis with inefficient maturation of blood cell precursors.
  • Approximately one-third of MDS patients transform into acute leukemia.
  • Characteristic karyotype anomalies, particularly involving chromosomes 5, 7, and 8, are observed in about half of patients.
  • Bone marrow insufficiency leading to pancytopenia and immune deficiency is common.
  • Etiology is largely unknown, but secondary MDS after chemotherapy/radiotherapy suggests environmental mutagen involvement.

Conclusions:

  • MDS serves as a model for monoclonal premalignant disorders.
  • Genetic abnormalities on chromosomes 5, 7, and 8 are significant in MDS pathogenesis.
  • While treatments are challenging, recent advancements offer improved prognosis, especially for younger patients.

Related Experiment Videos